In this issue
Cancer Biology & Therapy
Volume 13, Issue 7May 2012
View current issue
About the cover
The current standard of care for treating advanced stage head and neck squamous cell carcinoma is radiation therapy, with or without concurrent...Continue reading
Issue Highlights
Articles on:
- p63 expression correlates with sensitivity to the Eg5 inhibitor ZD4877 in bladder cancer cells
- Overexpression of IL-7 enhances cisplatin resistance in glioma
- Sensitization of (colon) cancer cells to death receptor related therapies: A report from the FP6-ONCODEATH research consortium
- Sorafenib inhibits endogenous and IL-6/S1P induced JAK2-STAT3 signaling in human neuroblastoma, associated with growth suppression and apoptosis
- P53 and the proteasome regulate androgen receptor activity
Upcoming Meetings
June 18-21, 2012
Lake Tahoe, Utah
June 27th - 29th,
Mykonos, Greece
in association with VIB- Cell Symposia
July 6 - 8, 2012
Leuven, Belgium
22nd Biennial Congress of the European Association for Cancer Research
July 7 - 10, 2012
Barcelona, Spain
Editor-in-Chief
Wafik S. El-Deiry, M.D., Ph.D.
Penn State University, Hershey, PA
Medline/PubMed, Scopus and in the Web of Science.
Open Access in Cancer Biology & Therapy
Cancer Biology & Therapy offers a highly competitive open access fee for authors who wish for free access to and distribution of published articles. Authors retain copyright of their work by utilizing a Creative Commons attribution license. Open Access papers will be submitted to PubMed Central immediately upon final publication of each issue.
The cost to make an original research paper OA is $750.00 USD.
For all other types of papers, the OA fee is $500.00 USD.
Find us on Facebook
Important Journal Links
CB&T News and Updates
Cancer News Daily - an aggregate news source of the most up-to-date cancer research
Download a PowerPoint presentation about Cancer Biology & Therapy. Created 04.16.2011, 5.9 MB
Update on guidelines for duplicate publications and guidelines for plagiarism; 05.15.2009
Plagiarism is Not Acceptable in Science or for Cancer Biology & Therapy; 06.2005
CB&T archives (published online for one year or longer) are freely available to all users. Full-text access is available via a link on the abstract page of each paper.
Most Popular Downloads
Hongxia Li, Quanli Gao, Liping Guo, et al.
Marco Rossi, Letizia Magnoni, Clelia Miracco, et al.
Toni M. Brand, Mari Iida and Deric L. Wheeler
Landes Highlights
Articles of interest recently published in our other journals
SFRP1 CpG island methylation locus is associated with renal cell cancer susceptibility and disease recurrence. Atschekzei et al. Epigenetics 7(5); May 2012.
Chk1 suppresses bypass of mitosis and tetraploidization in p53-deficient cancer cells. Deborah Wilsker, Jon H. Chung and Fred Bunz. Cell Cycle 11(8); April 15, 2012.
Low expression of Beclin 1, associated with high Bcl-xL, predicts a malignant phenotype and poor prognosis of gastric cancer. Zhou et al. Autophagy 8(3);March 2012.
Andrographolide sensitizes cisplatin-induced apoptosis via suppression of autophagosome-lysosome fusion in human cancer cells. Zhou et al. Autophagy 8(3);March 2012.
